Cookie Img
Home » Products » Pharmaceutical Injection » Adcetris Injection

Adcetris Injection

Adcetris Injection
Adcetris Injection
Product Code : AP/0003
Brand Name : Brentuximab vedotin
Product Specifications
  • Drug Type
  • Injection
  • Ingredients
  • Adcetris Injection
  • Suitable For
  • Adults
Product Description
ADCETRIS (brentuximab vedotin) is specified for treatment of patients with:
  • Classical Hodgkin lymphoma (HL) following non-working of autologous hematopoietic stem cell transplantation or auto-HSCT or following failure of minimum two prior multi-agent chemotherapy regimens in patients who are not auto-HSCT candidates.
  • Classical HL at elevated risk of relapse or development as post-auto-HSCT merging.
  • Systemic anaplastic large cell lymphoma or SALCL following failure of minimum one prior multi-agent chemotherapy regimen.
  • Enhanced approval was approved for the sALCL indication created on overall response rate. Continual approval for this sign may be dependent upon description and verification of clinical advantage in confirmatory trials.

ADCETRIS is contraindicated along with concomitant bleomycin because of pulmonary toxicity (e.g., inflammation/ interstitial infiltration).
Trade Information
  • Payment Terms
  • Cash Advance (CA), Delivery Point (DP), Western Union
  • Sample Available
  • Yes
  • Main Export Market(s)
  • Asia, Australia, Central America, North America, South America, Eastern Europe, Western Europe, Middle East, Africa
  • Main Domestic Market
  • All India


AMBICA PHARMA All Rights Reserved.